StonvexLoading…
StonvexStonvexStonvexCore line items from VTS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $81.81M | $67.41M | $273.99M | $215.37M | $147.93M |
Operating Income | Not available | $5.91M | $17.13M | $24.14M | $24.03M |
Net Income | Not available | $-42.28M | $25.28M | $26.02M | $24.66M |
EPS (Diluted) | $0.16 | $-1.05 | $0.64 | $0.67 | $0.72 |
Total Assets | Not available | $882.59M | $893.35M | $932.92M | $951.50M |
Total Liabilities | Not available | $312.14M | $264.03M | $282.67M | $279.63M |
Cash & Equivalents | Not available | $3.18M | $1.33M | $5.57M | $1.96M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 40.08M | 39.55M | 39.06M | 38.04M |